| Pharmaceutical Information |
| Drug Name |
Pentamidine |
| Drug ID |
BADD_D01717 |
| Description |
Antiprotozoal agent effective in trypanosomiasis, leishmaniasis, and some fungal infections; used in treatment of pneumocystis pneumonia in HIV-infected patients. It may cause diabetes mellitus, central nervous system damage, and other toxic effects. |
| Indications and Usage |
For the treatment of pneumonia due to Pneumocystis carinii. |
| Marketing Status |
Prescription; Discontinued |
| ATC Code |
P01CX01 |
| DrugBank ID |
DB00738
|
| KEGG ID |
D00834
|
| MeSH ID |
D010419
|
| PubChem ID |
4735
|
| TTD Drug ID |
D05EAM
|
| NDC Product Code |
Not Available |
| Synonyms |
Pentamidine | Pentamidin | Lomidine | NebuPent | Pentamidine Isethionate | Pentam | Pentamidine Mesylate | Diamidine | Pentacarinat |
|
| Chemical Information |
| Molecular Formula |
C19H24N4O2 |
| CAS Registry Number |
100-33-4 |
| SMILES |
C1=CC(=CC=C1C(=N)N)OCCCCCOC2=CC=C(C=C2)C(=N)N |
| Chemical Structure |
|
|
| ADR Related Proteins Induced by Drug |
| ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
| Not Available | Not Available | Not Available | Not Available | Not Available |
|
| ADRs Induced by Drug |
|
|
